Navigenics's alternatives and competitors
Avid is a clinical-stage product-focused molecular imaging company with IP in the field of molecular brain imaging. Per the company, Avid has developed targeting agent…
Top 10 Navigenics competitors
Compare Navigenics to Competitors
Viridis' equipment is a disease marker testing platform to be used at point-of-care.
Life Line Screening is a company focused on preventative health, operating within the healthcare sector. The company offers a range of health screening services, including cardiovascular and stroke screenings, liver, kidney, and diabetes screenings, as well as cancer and bone & joint screenings. These services are primarily aimed at individuals seeking to proactively manage their health and detect potential health risks early. It was founded in 1993 and is based in Cleveland, Ohio.
Genera Biosystems specializes in advanced molecular diagnostic systems within the biotechnology sector. The company offers products and services that facilitate multiplex quantitative polymerase chain reaction (qPCR) for research and clinical applications. It is based in Australia.
XEPTAGEN SpA is engaged in the discovery and validation of molecular markers in order to produce diagnostic kits for the early detection, monitoring, and screening of cancerous cells. By exploiting the natural immune response to early stage cancer and the platform technology Combinatorial Proteomic, XEPTAGEN has discovered specific tumor markers that lead to an earlier and much more accurate detection of developing carcinomas. The company's mission includes creating tools that improve the diagnostic accuracy for cancer and the clinical management of cancer patients.
Alerion Biomedical Inc. in San Diego is developing products for the detection, characterization and treatment of disease. The company is developing technologies aimed at studying and managing major diseases including cancer, vascular disorders and hepatobiliary disease. Alerion's latest product line, Fenestra, is revolutionizing the way in vivo imaging is used in basic research and drug development. Founded initially in 1997 as MetaProbe LLC by Research Corporation Technologies and the California Institute of Technology, Alerion Biomedical has grown to encompass a broad range of drug-delivery and medical imaging technologies. Advanced Research Technologies Inc., a Canadian medical device company, acquired substantially all of the imaging technology and product assets of Alerion in March 2006. ART is actively promoting the Fenestra product line.
3PrimiR is researching how mutations in micro RNA molecules can be used in cancer diagnostics.